NCT07830719: Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- State
- Under way
- Phase
- Phase 2
- People
- 180 planned
- Started
- 18 Sep 2026
- Primary completion
- 15 Aug 2027
- Arms
- YMI024 Dose 1, YMI024 Dose 2, YMI024 Dose 3, YMI024 Dose 4, YMI024 Dose 5
- Results
- None posted
- 18 Sep 2026: Trial started
- 21 Sep 2026: Trial registered